GlassScriptPhysician profile
Robert M Kimmel
NPI 1205808631
$3,157.85
in general payments reported to CMS, 2019-2025
17 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $33.44 · 2021: $134 · 2022: $1,597 · 2023: $378 · 2024: $602 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $1,229.11 | 2022 | |
| Mentor Worldwide LLC | $574.05 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Stryker Corporation | $444.32 | 2021-2024 | Medpor Titan, Smartlock, Delta |
| Allergan, INC. | $185.27 | 2020-2022 | |
| Smith+Nephew, INC. | $176.46 | 2019-2022 | |
| Merz North America, INC. | $134.93 | 2019 | |
| Abbvie INC. | $91.61 | 2023-2025 | |
| Axogen | $57.48 | 2019 | |
| Revance Therapeutics, INC. | $53.32 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $44.15 | 2024-2025 | |
| Globus Medical, INC. | $41.04 | 2022 | |
| Motiva USA, LLC | $36.29 | 2025 | |
| Solventum Corporation | $23.91 | 2025 | V.A.C. Granufoam, Activ.A.C. |
| Janssen Pharmaceuticals, INC | $19.66 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $17.07 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $16.65 | 2020 | |
| Olympus America INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kimmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.